US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 20.985
  • -0.225-1.06%
Trading Nov 21 14:56 ET
1.52BMarket Cap-174875P/E (TTM)

About Kiniksa Pharmaceuticals International Company

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Company Profile

SymbolKNSA
Company NameKiniksa Pharmaceuticals International
Listing DateMay 24, 2018
Issue Price18.00
Founded2024
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees297
Fiscal Year Ends12-31
Address23 Old Bond Street,3rd Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1S 4PZ
Phone44-781-431-9100
Websitehttps://www.kiniksa.com

Company Executives

  • Name
  • Position
  • Salary
  • Sanj K. Patel
  • Chief Executive Officer and Chairman of the Board
  • 5.30M
  • Michael R. Megna
  • Chief Accounting Officer and Group Vice President, Finance
  • --
  • Mark Ragosa
  • Senior Vice President and Chief Financial Officer
  • --
  • John F. Paolini, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 1.79M
  • Ross Moat
  • Senior Vice President and Chief Commercial Officer
  • --
  • Eben Tessari
  • Senior Vice President and Chief Operating Officer
  • 1.75M
  • Cantey Boyd
  • Director
  • --
  • Dr. Stephen R. Biggar,M.D.,PhD
  • Independent Director
  • 371.96K
  • Dr. Barry D. Quart,Pharm.D.
  • Independent Director
  • 372.55K
  • Kimberly J. Popovits
  • Independent Director
  • 362.66K
  • Tracey L. McCain, Esq.
  • Independent Director
  • 365.36K
  • Dr. Richard S. Levy,M.D.
  • Independent Director
  • 459.75K
  • Dr. Felix J. Baker,PhD
  • Lead Independent Director
  • 411.06K
  • G. Bradley Cole
  • Independent Director
  • 365.36K
  • Thomas R. Malley
  • Independent Director
  • 380.36K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data